Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction

Ayumu Hirata1, Norikazu Maeda, Hideaki Nakatsuji

  • 1Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, 2-2-B5 Yamada-oka, Suita, Osaka 565-0871, Japan. hirata@endmet.med.osaka-u.ac.jp

Abstract

Insights

Mineralocorticoid receptor (MR) blockade improves obesity-related issues by targeting glucocorticoids. This pathway may explain adipocytokine dysregulation and reactive oxygen species (ROS) in adipose tissue.

Area of Science:

  • Endocrinology
  • Metabolic Syndrome
  • Obesity Research

Background:

  • Mineralocorticoid receptor (MR) blockade shows promise in improving insulin resistance, adipocytokine dysregulation, inflammation, and reactive oxygen species (ROS) in obesity.
  • The precise mechanism by which MR blockade exerts these effects, particularly concerning the role of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and glucocorticoid action, remains unclear.

Purpose of the Study:

  • To investigate if glucocorticoids influence adipocytokines and ROS via MR in adipocytes.
  • To examine the distribution of MR and glucocorticoid receptor (GR) in human adipose tissue.

Main Methods:

  • Analysis of corticoid receptors and target genes in obese db/db mice adipose tissue.
  • Treatment of 3T3-L1 adipocytes with glucocorticoids, H2O2, MR antagonist eplerenone (EP), GR antagonist RU486 (RU), MR-siRNA, and N-acetylcysteine.
  • Investigation of MR and GR mRNA levels in human adipose tissue from patients undergoing abdominal surgery.

Main Results:

  • Obese mice exhibited higher mRNA levels of MR and its target genes compared to controls.
  • Glucocorticoids induced adipocytokine gene dysregulation and increased intracellular ROS in adipocytes, effects reversed by MR blockade but not GR antagonism.
  • Human visceral fat showed increased MR mRNA levels correlated with BMI, unlike GR mRNA levels.

Conclusions:

  • The glucocorticoid-MR pathway is implicated in obesity-related adipocytokine dysregulation and adipose tissue ROS.
  • MR blockade represents a potential therapeutic strategy for managing obesity-associated metabolic disturbances.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...